Longevity Pharmaceuticals

Acarbose

FDA approved

Also known as: Precose, Glucobay

Lifespan-extending diabetes drug — slows carb absorption, blunts post-meal glucose.

Open in AppAsk AI Advisor

Mechanism

Alpha-glucosidase inhibitor. Lifespan-extending diabetes drug — slows carb absorption, blunts post-meal glucose. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.

Peer-Reviewed Studies (2)

Acarbose Improves Health and Lifespan in HET3 Mice (NIA ITP)

Aging Cell · 2014

22% median lifespan extension in male mice.

PubMed PMID 24895291 →

Acarbose for Cardiovascular Prevention (ACE Trial)

Lancet Diab Endo · 2017

18% reduction in new-onset diabetes in CHD patients.

PubMed PMID 28855098 →

Related Compounds

Rapamycin

The only molecule shown to extend lifespan in every species tested — yeast to mammals.

Metformin

Most-prescribed diabetes drug, repurposed as the first FDA-approved aging trial.

Low-Dose Naltrexone (LDN)

Off-label utility player — autoimmune modulation, pain reduction, HPA-axis support.

SGLT2 Inhibitors (Empagliflozin)

Diabetes drug with off-label longevity interest — cardiac, renal, metabolic benefits.

Telmisartan

ARB blood pressure med with PPARγ activity — investigational longevity application.

Doxycycline (low-dose)

MMP modulator at sub-antibiotic dose — connective tissue, periodontal support.